{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-21-051123","form_type":"8-K","ticker":"NTRB","cik":"0001676047","company_name":"NutriBand Inc.","filed_at":"2021-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.603790+00:00","generated_at":"2026-06-28T23:59:46.509544+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nutriband receives USPTO Notice of Allowance for abuse-deterrent transdermal patent","bullets":["USPTO allowed patent application 16/707,547 on Sept 27, 2021.","Patent covers \"Abuse and Misuse Deterrent Transdermal Systems\".","Company expects U.S. patent to issue after administrative completion.","Strengthens Nutriband's IP portfolio for transdermal delivery platform."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-21-051123","json":"https://secwatch.observer/filing/0001213900-21-051123.json","markdown":"https://secwatch.observer/filing/0001213900-21-051123.md","text":"https://secwatch.observer/filing/0001213900-21-051123.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676047/000121390021051123/0001213900-21-051123-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676047/000121390021051123/ea148283-8k_nutriband.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:59:46.509544+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}